Geron Corp. : Geron to Present at the Stifel Healthcare Conference

      Geron Corp. : Geron to Present at the Stifel Healthcare Conference

MENLO PARK, Calif., September 4, 2013 - Geron Corporation (Nasdaq: GERN) today
announced that John Scarlett, M.D., President and Chief Executive Officer,
will present an overview of the company at 9:45 a.m. Eastern Time on
Wednesday, September 11, at the Stifel Nicolaus 2013 Healthcare Conference in

A live webcast of the presentation will be available at
Following the live presentation, the webcast will be archived and available
for replay at the same address for a period of 30 days.

About Geron

Geron is a clinical stage biopharmaceutical company developing a
first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid
malignancies. For more information about Geron, visit


Anna Krassowska, Ph.D.
Investor and Media Relations



This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Geron Corp. via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.